September 19, 2017/Orthoworld
Centinel Spine has entelaser back surgery recovery timered into an agreement to purchase DePuy Synthes’ worldwide prodisc assets. The acquisition is expected to close in mid-4Q17. Terms were not disclosed.
Upon completion, Centinel Spine will add cervical and lumbar artificial disc systems prodisc-C, prodisc-L, prodisc-C Vivo, prodisc-C Nova, prodisc-O and Discover to its portfolio, which presently includes MIDLINE and STALIF interbody devdevice companyices as well as ALTOS® posterior cervical stabilization, the ACTILIF™ Cervical Cage, etc.
The acquisition also serves as a catalyst for Centinel’s ex-U.S. expansion. The company has focused on the U.S. and Australian markets, and plans to use the prodisc portfolio to launch into more ex-U.S. markets, says John Viscogliosi, Chairman & Chief Executive Officer of Centinel Spine and a Principal at the private equity and venture capital firm Viscogliosi Bros., LLC.
Additionally, Viscogliosi told ORTHOWORLD, prodisc-C and prodisc-L are the only assets in the purchase with premarket approval in the U.S. Centinel intends to initiate U.S. clinical studies to secure approval for other products in the portfolio.
READ THE REST HERE
lumbar laminectomy discectomy